Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FDM07
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,587
Award facts
- Contract value 100% obligated
- $48,587.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $48.6K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 60 tablets of Jakafi 5 mg. This delivery order, issued on September 22, 2025, with an ultimate completion date of September 23, 2025, carries no set-aside designation. The award represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency, valued at $500M and valid through November 2026, which enables the agency to procure a comprehensive portfolio of pharmaceutical products supporting military health facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its status as a woman-owned small business to compete effectively in Defense Logistics Agency procurement markets. The company's core business involves distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities. Jakafi (ruxolitinib) is a prescription medication used primarily in hematologic conditions, and this delivery order fulfills an immediate medical supply requirement for military health services. The firm fixed-price structure and expedited completion timeline reflect the urgent nature of pharmaceutical supply procurement within the Defense Logistics Agency's mission to support military medical readiness.
Quick answers
Who was awarded contract SPE2DB25FDM07?
SPE2DB25FDM07 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FDM07 worth?
The government has obligated $48,587 on SPE2DB25FDM07.
Is contract SPE2DB25FDM07 an order under another contract?
Yes. SPE2DB25FDM07 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDM07 competed?
The extent of competition for SPE2DB25FDM07 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award